Report: Medtech tax has cost 33,000 jobs already

Survey: Medtech tax has cost 33,000 jobs already

The medical device industry has already lost some 33,000 jobs as a result of the medical device tax, according to a report from lobbying group AdvaMed.

Including indirect repercussions in related industries and the economy in general, AdvaMed estimated that as many as 165,000 jobs have been compromised due to the impact of the 2.3% medical device sales tax that took effect last year. The findings came from an AdvaMed survey of its member companies, using responses from 38 firms to extrapolate effects in the industry at large.

"Contrary to the claims of some of the proponents of this tax, companies are simply not able to pass the tax on and are not anticipating a windfall from expanded coverage," AdvaMed president & CEO Stephen Ubl said in a conference call with reporters today. "At a time when unemployment remains at historic highs and there is bipartisan interest in growing advanced manufacturing jobs here in America, our industry is experiencing an unprecedented real-world negative impact on jobs and R&D due to this tax."

In addition to layoffs, device makers slashed their R&D budgets, reduced employee pay, moved manufacturing overseas, reduced spending in start-ups, canceled or put off new facilities and took other actions to deal with the cost of the new levy, according to the report.

The results paralleled some findings from a recent Emergo Group survey that similarly reported lowered R&D spending and job losses in 2013 as a result of the medical device tax. The Emergo survey, however, also found that fewer medtech executives reported negative effects overall than had been expected. An increasing percentage reported that the tax had no impact on their company in 2013.

"Overall, the impact of the [medical device excise tax] is being felt by industry, but the impact seems to be less severe than depicted by the media and industry organizations," according to Emergo.

AdvaMed’s survey brought a far different message, highlighting that a significant number of survey respondents said that they slashed their R&D budgets, moved jobs overseas and took other undesirable steps in response to the tax. Looking forward, half said they would continue lowering R&D and 58% said they would consider additional layoffs if the tax were not repealed.

"As a start-up company getting ready to launch a product, the [medical device excise tax] will create a $300K potential debt/cash-flow problem," one anonymous respondent wrote. "I can’t afford to be successful!"

"We are likely to close a U.S. plant which will offset about 70-80% of the cost of the MDET," wrote another.

AdvaMed’s survey included companies from 17 U.S. states, representing offices and jobs in all 50 states. Companies were split about halfway between revenues under $100 million and those with higher sales, and 40% were operating at an annual loss. In total, the companies represented $35.5 billion in annual revenue, about 22% of the total industry.

The lobbying group has been actively fighting the medical device tax since its inception during discussions that shaped the Affordable Care Act, but has been stone-walled in part by difficulties finding a way to make up for lost federal revenues. The tax is slated to bring in about $30 billion to help fund healthcare reform, and AdvaMed and other industry groups have maintained that finding a so-called "pay-for" to replace that funding is a task best left to Congress.

"We’re ambivalent about the funding source for repeal," AdvaMed chairman and Zimmer Holdings (NYSE:ZMH) president & CEO David Dvorak said during today’s call. "This is a new year and potential pay-fors are yet to be identified. We, frankly, believe that it’s a matter that policy-makers ought to take on."

Repeal efforts have garnered significant attention and support from both sides of the aisle. A House bill to repeal the levy has 270 co-sponsors, including 43 Democrats, Dvorak said. The Senate version has 38 co-sponsors, including 6 Democrats.

Calls for repeal continue to gain lawmaker support, but previous pay-for proposals have rubbed Democrats the wrong way and President Barack Obama has on more than 1 occasion promised to veto a device tax repeal bill should one land on his desk. Former President Bill Clinton reiterated the importance of finding a pay-for, telling an audience of healthcare stakeholders in Laguna Beach, Calif., last monthly that efforts to repeal the medical device tax must come with a strategy to make up the lost funds.

"You’ve got medical device people, they hate the tax," Clinton said during January’s Patient Safety, Science & Technology Summit. "If you want to get rid of it you’ve got to say how you’d replace it."

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply